Annika Anderson
Analysis Group (United States)(US)
Publications by Year
Research Areas
Renal Diseases and Glomerulopathies, Cytomegalovirus and herpesvirus research, Complement system in diseases, Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research
Most-Cited Works
- → The Economic Burden of Schizophrenia in the United States(2022)183 cited
- → Maralixibat Treatment Response in Alagille Syndrome is Associated with Improved Health-Related Quality of Life(2022)26 cited
- → Application of Nucleotide-Based Kinetic Modeling Approaches to Predict Antibiotic Resistance Gene Degradation during UV- and Chlorine-Based Wastewater Disinfection Processes: From Bench- to Full-Scale(2022)19 cited
- → Health care costs among patients with hematologic malignancies receiving allogeneic transplants: a US payer perspective(2023)10 cited
- → The Economic Burden of Schizophrenia in the United States in 2019(2022)9 cited
- → Health Care Resource Utilization by Patients with Alagille Syndrome(2022)6 cited
- → Costs of pediatric liver transplantation among commercially insured and Medicaid-insured patients with cholestasis in the US(2023)6 cited
- → Patient and Caregiver Outcomes After Onasemnogene Abeparvovec Treatment: Findings from the Cure SMA 2021 Membership Survey(2023)6 cited
- → Economic burden during remission and after relapse among older patients with newly diagnosed acute myeloid leukemia without hematopoietic stem cell transplant: A retrospective study using the SEER-Medicare database(2023)4 cited
- → Epidemiology and Economic Burden of Diagnosed Congenital Cytomegalovirus Infection in the First 2 Years of Life among Commercially Insured and Medicaid-Insured Individuals in the United States(2025)4 cited